Barbara M. Schultz

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Journal: iScience

Published: February 14, 2025

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Journal: EBioMedicine

Published: December 19, 2022

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Journal: mBio

Published: November 16, 2022

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

Journal: mBio

Published: August 10, 2022

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Journal: eLife

Published: June 29, 2022

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.

Journal: medRxiv : the preprint server for health sciences

Published: April 20, 2022

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.

Journal: medRxiv : the preprint server for health sciences

Published: April 20, 2022

Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection.

Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection.

Journal: Antioxidants (Basel, Switzerland)

Published: March 07, 2022

Distal Consequences of Mucosal Infections in Intestinal and Lung Inflammation.

Distal Consequences of Mucosal Infections in Intestinal and Lung Inflammation.

Journal: Frontiers in immunology

Published: February 16, 2022

Role of Extracellular Trap Release During Bacterial and Viral Infection.

Role of Extracellular Trap Release During Bacterial and Viral Infection.

Journal: Frontiers in microbiology

Published: October 20, 2021

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.

Journal: Frontiers in immunology

Published: July 26, 2021

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.

Journal: Frontiers in immunology

Published: July 16, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026